Company / Cash per Share
Boston Scientific Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.31
FY2025
5-year range
$0.28 / $1.31
FY2021-FY2025
Trend
+371.9%
vs FY2024
Sector context
#105 of 146
Health Care
What the data says
Cash per Share changed +372% YoY in FY2025, a notable deviation from the 9-year average annual change of +108%.
Based on SEC 10-K filings.
1.31 in FY2025 with a 5-year CAGR of +53.4%.
Improved from $0.60 to $1.31 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +26.8%
- 5-Year CAGR
- +53.4%
- 10-Year CAGR
- -
Sector benchmark
#105 of 146 in Health CareTop 72% of 146This company $1.31 Sector average $27.73
▼
-95.3% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 371.9% year-over-year.
- Ranks #105 out of 146 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.31 | +371.9% |
| FY2024 | $0.28 | -53.8% |
| FY2023 | $0.60 | -6.4% |
| FY2022 | $0.64 | -47.6% |
| FY2021 | $1.23 | +693.9% |
| FY2020 | $0.15 | -0.5% |
| FY2019 | $0.16 | +47.5% |
| FY2018 | $0.11 | -23.0% |
| FY2017 | $0.14 | -6.0% |
| FY2016 | $0.15 | -39.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026